-
CGH: Serum carboxypeptidase activity and genotype-stratified CA19-9 levels can detect the development of early pancreatic cancer
Time of Update: 2022-10-31
Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer.
Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer.
Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer.
Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer.
-
Cancer Res: Tang Fu-Hui/Cui Heng/Ji Jia-kui collaborate to reveal molecular regulatory mechanisms for high-grade serous ovarian cancer
Time of Update: 2022-09-06
In order to fully reveal the molecular characteristics and interplay between different omics levels of high-grade serous ovarian cancer in the process of occurrence and development, Tang Fuhui Research Group of Peking University Biomedical Frontier Innovation Center cooperated with Cui Heng Research Group of Peking University People's Hospital and Ji Jiakui Research Group of Tsinghua University to conduct high-precision single-cell multi-omics sequencing analysis (genome (copy number variation), chromatin status group, DNA methylation group, transcriptome.
-
Junshi Biosciences completes the first patient dosing in the JUPITER-15 study of toripalimab
Time of Update: 2022-05-03
Li Guoxin from Nanfang Hospital of Southern Medical University Led the lead, aiming to evaluate the clinical efficacy and safety of toripalimab versus placebo combined with standard chemotherapy as postoperative adjuvant therapy for patients with gastric or esophagogastric junction adenocarcinoma after radical resection.
-
npj Precis Onc: Scientists reveal new mechanism of melanoma resistance to therapy
Time of Update: 2022-04-29
Recently, a research report entitled "Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients" was published in the international journal npj Precision Oncology, from Vanderbilt University Medical Center and other institutions.
-
"Ancient Early" research has been featured in the JAMA sub-journal after 20 years because
Time of Update: 2022-03-08
Recently, a cohort study investigating the optimal duration of androgen deprivation therapy after radiotherapy in high-risk prostate cancer patients was published in JAMA Oncology .
-
Transl Lung Cancer Res: Efficacy of chemotherapy-antiangiogenic versus chemotherapy-immunotherapy combination therapy in patients with EGFR-mutant advanced NSCLC after failure of EGFR-TKI therapy
Time of Update: 2022-03-04
We screened patients with advanced NSCLC with EGFR mutations diagnosed between January 2015 and December 2020, who received chemotherapy-antiangiogenic or chemotherapy-immunotherapy combination therapy after EGFR-TKI resistance .
-
Thorac Cancer: Maintenance therapy with apatinib after standard first-line chemotherapy in patients with extensive-stage small cell lung cancer (ED-SCLC) further prolongs survival
Time of Update: 2022-01-23
hypertension Adverse reactionsAdverse reactionsIn conclusion, studies have shown that maintenance therapy with apatinib after standard first-line chemotherapy in patients with extensive-stage small cell lung cancer (ED-SCLC) can further prolong survival, but the number of specimens is small, and further exploration is needed in the future .
-
Cancer Discovery (IF=39) Wan Fengyi's team discovered the underlying mechanism of bacterial gene toxins driving colon tumors
Time of Update: 2022-01-10
The research report UshA is A new type of attaching/effacing (A/E) pathogen gene toxin, including human pathogen enteropathogenic Escherichia coli, enterohemorrhagic Escherichia coli and its mouse equivalent Citrobacter rodentium (CR) .
-
DCR: Myocardial injury after colorectal cancer surgery is closely related to 90-day mortality after surgery
Time of Update: 2021-12-26
The purpose of this study is to explore the incidence of myocardial injury in patients undergoing colorectal cancer surgery in the accelerated rehabilitation program and its relationship with 90-day mortality and morbidity.
Myocardial Injury After Colorectal Cancer Surgery and Postoperative 90-Day Mortality and Morbidity: A Retrospective Cohort Study.
-
Express delivery of 100% of patients achieved complete remission, and the Phase 2 clinical results of the oncolytic virus/PD-1 antibody combination are positive
Time of Update: 2021-12-07
▎The content team editor of WuXi AppTec recently, CG Oncology announced the preliminary results of phase 2 clinical trials of its oncolytic virus therapy CG0070, combined with the heavy anti-PD-1 antibody Keytruda, in the treatment of non-muscular invasive bladder cancer , These patients did not respond to BCG treatment .
-
Radiology: For patients with papillary thyroid carcinoma, this technique must be known
Time of Update: 2021-08-26
Microwave ablation (MWA) and radiofrequency ablation (RFA) as minimally invasive treatments for papillary thyroid carcinoma (PTC) have attracted much attention in recent years .
US-guided thermal ablation methods, including microwave ablation (MWA) and radiofrequency ablation (RFA), have recently attracted more and more attention as a minimally invasive treatment for thyroid tumors .
-
New insights on how to stop the transcription of cancer cells
Time of Update: 2021-07-27
FindScientists from the Jonsson Comprehensive Cancer Center at UCLA have identified a key protein, the transcription factor TAF12, which plays a key role in the formation of the pre-initiation complex, which is composed of more than 100 proteins.
-
Proton Biotech announced that it has reached a strategic cooperation with Kaidi Biotech to accelerate the development and production of CAR-T drugs
Time of Update: 2021-07-06
According to the agreement, Proton Bio will serve as the exclusive CDMO partner to provide CMC research and development services for multiple CAR-T projects, including the process development and production of plasmids, viral vectors and CAR-T cells, and the IND registration of the CMC part.
-
Heavy discovery | God's journal CA announces the reasons for the decline in cancer deaths in the United States
Time of Update: 2021-01-23
although the risk of lung cancer from smoking was small, the incidence of non-smoking-related lung cancer was much higher in women than in men.
same time, the overall death rate in the United States fell by 7.7 percent between 2014 and 2018, 46 percent of which was due to lung cancer.
-
Br J Cancer: The new CD63-BCAR4 fusion protein promotes tumor-causing and metastasis of lung adenocarcinoma
Time of Update: 2020-11-25
based on RNA sequencing data analysis, the researchers identified a fusion transcript of CD63-BCAR4 in a Korean lung adenocarcinoma patient who did not carry a known activation mutation of the EGFR and KRAS genes, and studied the carcinogenic effects of CD63-BCAR4 in further experiments.
